XML 33 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Stock-based Compensation
12 Months Ended
Feb. 25, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
13.
STOCK-BASED COMPENSATION
 
The Company measures all employee stock-based compensation awards using a fair value method and records such expense, net of estimated forfeitures, in its consolidated financial statements. Currently, the Company’s stock-based compensation relates to restricted stock awards, stock options and performance stock units. The Company’s restricted stock awards are considered nonvested share awards.
 
Stock-based compensation expense for the fiscal year ended
February
25,
2017,
February
27,
2016
and
February
28,
2015
was approximately
$71.9
million
($46.3
million after tax or
$0.31
per diluted share), approximately
$67.0
million
($42.4
million after tax or
$0.26
per diluted share) and approximately
$66.5
million
($42.4
million after tax or
$0.22
per diluted share), respectively. In addition, the amount of stock-based compensation cost capitalized for the years ended
February
25,
2017
and
February
27,
2016
was approximately
$2.2
million and
$2.1
million, respectively.
 
Incentive Compensation Plans
 
The Company currently grants awards under the Bed Bath & Beyond
2012
Incentive Compensation Plan (the
“2012
Plan”), which amended and restated the Bed Bath & Beyond
2004
Incentive Compensation Plan (the
“2004
Plan”). The
2012
Plan includes an aggregate of
43.2
million common shares authorized for issuance and the ability to grant incentive stock options. Outstanding awards that were covered by the
2004
Plan continue to be in effect under the
2012
Plan.
 
The
2012
Plan is a flexible compensation plan that enables the Company to offer incentive compensation through stock options (whether nonqualified stock options or incentive stock options), restricted stock awards, stock appreciation rights, performance awards and other stock based awards, including cash awards. Under the
2012
Plan, grants are determined by the Compensation Committee for those awards granted to executive officers and by an appropriate committee for all other awards granted. Awards of stock options and restricted stock generally vest in
five
equal annual installments beginning
one
to
three
years from the date of grant. Awards of performance stock units generally vest over a period of
four
years from the date of grant dependent on the Company’s achievement of performance-based tests and subject, in general, to the executive remaining in the Company’s service on specified vesting dates.
 
The Company generally issues new shares for stock option exercises, restricted stock awards and vesting of performance stock units.
 
Stock Options
 
Stock option grants are issued at fair market value on the date of grant and generally become exercisable in either
three
or
five
equal annual installments beginning
one
year from the date of grant for options issued since
May
10,
2010,
and beginning
one
to
three
years from the date of grant for options issued prior to
May
10,
2010,
in each case, subject, in general to the recipient remaining in the Company’s service on specified vesting dates. Option grants expire
eight
years after the date of grant. All option grants are nonqualified. As of
February
25,
2017,
unrecognized compensation expense related to the unvested portion of the Company’s stock options was
$21.0
million, which is expected to be recognized over a weighted average period of
2.9
years.
 
The fair value of the stock options granted was estimated on the date of the grant using a Black-Scholes option-pricing model that uses the assumptions noted in the following table.
 
    FISCAL YEAR ENDED
Black-Scholes Valuation Assumptions  (1)   February
25, 2017
  February
27, 2016
  February
28, 2015
             
Weighted Average Expected Life (in years)  (2)    
6.6
     
6.7
     
6.6
 
Weighted Average Expected Volatility  (3)    
26.96
%    
27.59
%    
28.31
%
Weighted Average Risk Free Interest Rates  (4)    
1.46
%    
1.93
%    
2.11
%
Expected Dividend Yield (5)    
1.10
%    
-
     
-
 
 
(1)
Forfeitures are estimated based on historical experience.
(2)
The expected life of stock options is estimated based on historical experience.
(3)
Expected volatility is based on the average of historical and implied volatility. The historical volatility is determined by observing actual prices of the Company’s stock over a period commensurate with the expected life of the awards. The implied volatility represents the implied volatility of the Company’s call options, which are actively traded on multiple exchanges, had remaining maturities in excess of
twelve
months, had market prices close to the exercise prices of the employee stock options and were measured on the stock option grant date.
(4)
Based on the U.S. Treasury constant maturity interest rate whose term is consistent with the expected life of the stock options.
(5)
Expected dividend yield is estimated based on anticipated dividend payouts.
 
Changes in the Company’s stock options for the fiscal year ended
February
25,
2017
were as follows:
 
(Shares in thousands)   Number of Stock Options   Weighted Average
Exercise Price
Options outstanding, beginning of period    
3,838
    $
54.43
 
Granted    
703
     
45.53
 
Exercised    
(635
)    
31.94
 
Forfeited or expired    
-
     
-
 
Options outstanding, end of period    
3,906
    $
56.48
 
Options exercisable, end of period    
2,262
    $
55.02
 
 
The weighted average fair value for the stock options granted in fiscal
2016,
2015
and
2014
was
$11.87,
$23.12
and
$20.96,
respectively. The weighted average remaining contractual term and the aggregate intrinsic value for options outstanding as of
February
25,
2017
was
4.0
years and
$4.6
million, respectively. The weighted average remaining contractual term and the aggregate intrinsic value for options exercisable as of
February
25,
2017
was
2.6
years and
$4.6
million, respectively. The total intrinsic value for stock options exercised during fiscal
2016,
2015
and
2014
was
$9.0
million,
$8.7
million and
$33.5
million, respectively.
 
Net cash proceeds from the exercise of stock options for fiscal
2016
were
$20.4
million and the net associated income tax benefit was
$0.4
million.
 
Restricted Stock
 
Restricted stock awards are issued and measured at fair market value on the date of grant and generally become vested in
five
equal annual installments beginning
one
to
three
years from the date of grant, subject, in general, to the recipient remaining in the Company’s service on specified vesting dates. Vesting of restricted stock awarded to certain of the Company’s executives is dependent on the Company’s achievement of a performance-based test for the fiscal year of grant and, assuming achievement of the performance-based test, time vesting, subject, in general, to the executive remaining in the Company’s service on specified vesting dates. The Company recognizes compensation expense related to these awards based on the assumption that the performance-based test will be achieved. Vesting of restricted stock awarded to the Company’s other employees is based solely on time vesting. As of
February
25,
2017,
unrecognized compensation expense related to the unvested portion of the Company’s restricted stock awards was
$132.7
million, which is expected to be recognized over a weighted average period of
4.1
years.
 
Changes in the Company’s restricted stock for the fiscal year ended
February
25,
2017
were as follows:
 
(Shares in thousands)   Number of Restricted Shares   Weighted Average
Grant-Date Fair
Value
Unvested restricted stock, beginning of period    
3,230
    $
62.71
 
Granted    
1,287
     
44.83
 
Vested    
(834
)    
55.13
 
Forfeited    
(191
)    
59.29
 
Unvested restricted stock, end of period    
3,492
    $
58.12
 
 
Performance Stock Units
 
Performance stock units (“PSUs”) are issued and measured at fair market value on the date of grant. Vesting of PSUs awarded to certain of the Company’s executives is dependent on the Company’s achievement of a performance-based test during a
one
-year period from the date of grant and during a
three
-year period from the date of grant and, assuming achievement of the performance-based test, time vesting over periods of up to
four
years, subject, in general, to the executive remaining in the Company’s service on specified vesting dates. Performance during the
one
-year period will be based on Earnings Before Interest and Taxes (“EBIT”) margin relative to a peer group of the Company and performance during the
three
-year period will be based on Return on Invested Capital (“ROIC”) relative to such peer group. The awards based on EBIT margin and ROIC range from a floor of
zero
to a cap of
150%
of target achievement. PSUs are converted into shares of common stock upon payment following vesting. Upon grant of the PSUs, the Company recognizes compensation expense related to these awards based on the assumption that
100%
of the target award will be achieved. The Company evaluates the target assumption on a quarterly basis and adjusts compensation expense related to these awards, as appropriate. As of
February
25,
2017,
unrecognized compensation expense related to the unvested portion of the Company’s performance stock units was
$23.7
million, which is expected to be recognized over a weighted average period of
1.8
years.
 
Changes in the Company’s PSUs for the fiscal year ended
February
25,
2017
were as follows:
 
(Shares in thousands)   Number of Performance
Stock Units
  Weighted Average
Grant-Date Fair
Value
Unvested performance stock units, beginning of period    
627
    $
67.15
 
Granted    
566
     
45.53
 
Vested    
(179
)    
66.53
 
Forfeited    
-
     
-
 
Unvested performance stock units, end of period    
1,014
    $
55.19